Cargando…

Antibody-Mediated LILRB2-Receptor Antagonism Induces Human Myeloid-Derived Suppressor Cells to Kill Mycobacterium tuberculosis

Tuberculosis is a leading cause of death in mankind due to infectious agents, and Mycobacterium tuberculosis (Mtb) infects and survives in macrophages (MФs). Although MФs are a major niche, myeloid-derived suppressor cells (MDSCs) are an alternative site for pathogen persistence. Both MФs and MDSCs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Vipul K., Khan, Arshad, Xu, Yitian, Mai, Sunny, Zhang, Licheng, Mishra, Abhishek, Restrepo, Blanca I., Pan, Ping-Ying, Chen, Shu-Hsia, Jagannath, Chinnaswamy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229593/ https://www.ncbi.nlm.nih.gov/pubmed/35757769 http://dx.doi.org/10.3389/fimmu.2022.865503

Ejemplares similares

Human Macrophages Exhibit GM-CSF Dependent Restriction of Mycobacterium tuberculosis Infection via Regulating Their Self-Survival, Differentiation and Metabolism
por: Mishra, Abhishek, et al.
Publicado: (2022)

Multi-OMICs analysis reveals metabolic and epigenetic changes associated with macrophage polarization
por: Sowers, Mark L., et al.
Publicado: (2022)

Sirtuin-dependent metabolic and epigenetic regulation of macrophages during tuberculosis
por: Zhang, Kangling, et al.
Publicado: (2023)

GM-CSF Dependent Differential Control of Mycobacterium tuberculosis Infection in Human and Mouse Macrophages: Is Macrophage Source of GM-CSF Critical to Tuberculosis Immunity?
por: Mishra, Abhishek, et al.
Publicado: (2020)

LILRB4, an immune checkpoint on myeloid cells
por: Yang, Ting, et al.
Publicado: (2022)

Emerging Prevention and Treatment Strategies to Control COVID-19
por: Singh, Vipul K., et al.
Publicado: (2020)

LILRB2-containing small extracellular vesicles from glioblastoma promote tumor progression by promoting the formation and expansion of myeloid-derived suppressor cells
por: Wu, Peitao, et al.
Publicado: (2023)

The impact of HLA-G, LILRB1 and LILRB2 gene polymorphisms on susceptibility to and severity of endometriosis
por: Bylińska, Aleksandra, et al.
Publicado: (2017)

Correction to: LILRB2-containing small extracellular vesicles from glioblastoma promote tumor progression by promoting the formation and expansion of myeloid-derived suppressor cells
por: Wu, Peitao, et al.
Publicado: (2023)

LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation
por: Yeboah, Muchaala, et al.
Publicado: (2020)

A heparan-sulfate-bearing syndecan-1 glycoform is a distinct surface marker for intra-tumoral myeloid-derived suppressor cells
por: Welte, Thomas, et al.
Publicado: (2021)

Structures of the four Ig-like domain LILRB2 and the four-domain LILRB1 and HLA-G1 complex
por: Wang, Qihui, et al.
Publicado: (2019)

Prophylactic Sublingual Immunization with Mycobacterium tuberculosis Subunit Vaccine Incorporating the Natural Killer T Cell Agonist Alpha-Galactosylceramide Enhances Protective Immunity to Limit Pulmonary and Extra-Pulmonary Bacterial Burden in Mice
por: Khan, Arshad, et al.
Publicado: (2017)

Commentary: Bettering BCG: a tough task for a TB vaccine?
por: Srivastava, Brahm S., et al.
Publicado: (2019)

Molecular regulatory mechanism of LILRB4 in the immune response
por: LIU, Haiyin, et al.
Publicado: (2023)

The fbpA/sapM Double Knock Out Strain of Mycobacterium tuberculosis Is Highly Attenuated and Immunogenic in Macrophages
por: Saikolappan, Sankaralingam, et al.
Publicado: (2012)

HLA-G, LILRB1 and LILRB2 Variants in Zika Virus Transmission from Mother to Child in a Population from South and Southeast of Brazil
por: de Moraes, Amarilis Giaretta, et al.
Publicado: (2022)

Structural basis for RIFIN-mediated activation of LILRB1 in malaria
por: Harrison, Thomas E., et al.
Publicado: (2020)

LILRB3 suppresses immunity in glioma and is associated with poor prognosis
por: Zhuang, Qiyuan, et al.
Publicado: (2023)

LILRA3 Binds Both Classical and Non-Classical HLA Class I Molecules but with Reduced Affinities Compared to LILRB1/LILRB2: Structural Evidence
por: Ryu, Myongchol, et al.
Publicado: (2011)

The inhibitory receptor LILRB4 (ILT3) modulates antigen presenting cell phenotype and, along with LILRB2 (ILT4), is upregulated in response to Salmonella infection
por: Brown, Damien P, et al.
Publicado: (2009)

Pan-cancer analysis reveals distinct clinical, genomic, and immunological features of the LILRB immune checkpoint family in acute myeloid leukemia
por: Xu, Zi-jun, et al.
Publicado: (2022)

Bacterial Killing Activity of Polymorphonuclear Myeloid-Derived Suppressor Cells Isolated From Tumor-Bearing Dogs
por: Hlavaty, Sabina I., et al.
Publicado: (2019)

KIR, LILRB and their Ligands’ Genes as Potential Biomarkers in Recurrent Implantation Failure
por: Nowak, Izabela, et al.
Publicado: (2017)

Structural basis of malaria RIFIN binding by LILRB1-containing antibodies
por: Chen, Yiwei, et al.
Publicado: (2021)

NOD2/RIG-I Activating Inarigivir Adjuvant Enhances the Efficacy of BCG Vaccine Against Tuberculosis in Mice
por: Khan, Arshad, et al.
Publicado: (2020)

A recombinant bovine adenoviral mucosal vaccine expressing mycobacterial antigen-85B generates robust protection against tuberculosis in mice
por: Khan, Arshad, et al.
Publicado: (2021)

B7-H3 Promotes Prostate Cancer Progression in Mice by Antagonizing Myeloid-Derived Suppressor Cell Apoptosis
por: Zhou, Yunfen, et al.
Publicado: (2020)

Pleiotropic tumor suppressor functions of WWOX antagonize metastasis
por: Khawaled, Saleh, et al.
Publicado: (2020)

Mycobacterium tuberculosis and myeloid-derived suppressor cells: Insights into caveolin rich lipid rafts
por: Kotzé, Leigh A., et al.
Publicado: (2020)

Expression of the innate immune receptor LILRB5 on monocytes is associated with mycobacteria exposure
por: Hogan, Louise E., et al.
Publicado: (2016)

ANGPTL2/LILRB2 signaling promotes the propagation of lung cancer cells
por: Liu, Xiaoye, et al.
Publicado: (2015)

A common missense variant of LILRB5 is associated with statin intolerance and myalgia
por: K Siddiqui, Moneeza, et al.
Publicado: (2017)

LILRB4 signaling in leukemia cells mediates T cell suppression and tumor infiltration
por: Deng, Mi, et al.
Publicado: (2018)

LILRB4 suppresses immunity in solid tumors and is a potential target for immunotherapy
por: Sharma, Naveen, et al.
Publicado: (2021)

LILRB2-mediated TREM2 signaling inhibition suppresses microglia functions
por: Zhao, Peng, et al.
Publicado: (2022)

Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer
por: Zeller, Tobias, et al.
Publicado: (2023)

LILRB2/PirB mediates macrophage recruitment in fibrogenesis of nonalcoholic steatohepatitis
por: Li, Dan-Pei, et al.
Publicado: (2023)

Distinct frequency patterns of LILRB3 and LILRA6 allelic variants in Europeans
por: Bashirova, Arman A., et al.
Publicado: (2022)

LILRB2 Interaction with HLA Class I Correlates with Control of HIV-1 Infection
por: Bashirova, Arman A., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_guu0mm8lphqbfkltahlpspokib